Terms: = Ovarian cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Diagnosis
15 results:
1. Imaging in gynecological disease (24): clinical and ultrasound characteristics of ovarian mature cystic teratomas.
Heremans R; Valentin L; Sladkevicius P; Timmerman S; Moro F; Van Holsbeke C; Epstein E; Testa AC; Timmerman D; Froyman W
Ultrasound Obstet Gynecol; 2022 Oct; 60(4):549-558. PubMed ID: 35316568
[TBL] [Abstract] [Full Text] [Related]
2. circCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate brd4 signals.
Zeng XY; Yuan J; Wang C; Zeng D; Yong JH; Jiang XY; Lan H; Xiao SS
Mol Med; 2020 Jul; 26(1):70. PubMed ID: 32640974
[TBL] [Abstract] [Full Text] [Related]
3. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
Guo CM; Liu SQ; Sun MZ
Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
[TBL] [Abstract] [Full Text] [Related]
4. Commonest cancers in Pakistan - Findings and Histopathological Perspective from a Premier Surgical Pathology Center in Pakistan.
Ahmad Z; Idrees R; Fatima S; Uddin N; Ahmed A; Minhas K; Memon A; Fatima SS; Arif M; Hasan S; Ahmed R; Pervez S; Kayani N
Asian Pac J Cancer Prev; 2016; 17(3):1061-75. PubMed ID: 27039726
[TBL] [Abstract] [Full Text] [Related]
5. NUT midline carcinoma presenting with bilateral ovarian metastases: a case report.
Dragoescu E; French C; Cassano A; Baker S; Chafe W
Int J Gynecol Pathol; 2015 Mar; 34(2):136-42. PubMed ID: 25675182
[TBL] [Abstract] [Full Text] [Related]
6. [A case of solitary splenic metastasis from an ovarian cancer 12 years after primary resection].
Hasegawa H; Naitoh H; Tsuchihashi H; Okada K; Furukawa H; Hanasawa K
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1799-803. PubMed ID: 20841951
[TBL] [Abstract] [Full Text] [Related]
7. [A 52 year-old woman with fever, cough and dyspnoea].
Palma Modoni A; De Galasso L; Scriccia S; Milanetti F; Sgambato E; Spoto S; Costantino S
Clin Ter; 2004 Sep; 155(9):401-4. PubMed ID: 15700634
[TBL] [Abstract] [Full Text] [Related]
8. [Primary peritoneal malignant tumor: clinical analysis of 28 cases].
Wu Y; Li WF
Ai Zheng; 2003 Nov; 22(11):1228-31. PubMed ID: 14613659
[TBL] [Abstract] [Full Text] [Related]
9. Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases.
Itoh K; Yamashita T; Wakita H; Watanabe Y; Kodama K; Fujii H; Minami H; Ohtsu T; Igarashi T; Sasaki Y
Jpn J Clin Oncol; 1998 May; 28(5):343-6. PubMed ID: 9703864
[TBL] [Abstract] [Full Text] [Related]
10. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
[TBL] [Abstract] [Full Text] [Related]
11. [A case of solitary metastatic splenic tumor of ovarian carcinoma].
Kobayashi A; Yamaguchi M; Koarai N; Sugizaki N
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1341-5. PubMed ID: 9279357
[TBL] [Abstract] [Full Text] [Related]
12. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).
Price FV; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1993 Dec; 51(3):383-9. PubMed ID: 8112650
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic factors in advanced ovarian carcinoma.
Redman JR; Petroni GR; Saigo PE; Geller NL; Hakes TB
J Clin Oncol; 1986 Apr; 4(4):515-23. PubMed ID: 3958765
[TBL] [Abstract] [Full Text] [Related]
14. Adenomyosis: study in a Jewish female population.
Blum M
Int Surg; 1981; 66(4):341-3. PubMed ID: 7345047
[TBL] [Abstract] [Full Text] [Related]
15. Early primary diagnosis of ovarian cancer and detection of recurrence by serum cystine aminopeptidase assay.
Kalinkov D; Buchholz R
Am J Obstet Gynecol; 1980 Dec; 138(8):1148-50. PubMed ID: 7446622
[TBL] [Abstract] [Full Text] [Related]